A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy People

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 administrations of multiple rising doses.
Epistemonikos ID: 06ad451b824d517250b3ac29869b8fe418e6bb6e
First added on: Oct 31, 2026